2276. Immunogenicity of Takeda’s Bivalent Virus-Like Particle (VLP) Norovirus Vaccine (NoV) Candidate in Children From 6 Months up to 4 Years of Age

BACKGROUND: With the introduction of routine childhood rotavirus vaccination, norovirus is now becoming the major cause of medically-attended gastroenteritis in children. Takeda is developing a norovirus vaccine (NoV) that contains genotypes GI.1 and GII.4 consensus (GII.4c) sequence VLPs. We report...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Open Forum Infect Dis
Main Authors: Masuda, Taisei, Lefevre, Inge, Mendelman, Paul, Sherwood, Jim, Bizjajeva, Svetlana, Borkowski, Astrid
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2018
Teme:
Abstracts
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6255068/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.1929
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki